Scaling up and out: developing a commercial supply chain strategy to successfully deliver next-generation therapiesPublished: January 13, 2020
Thursday, 6th February 8:00 PST; 11:00 EST; 16:00 GMT; 17:00 CET
With the introduction of innovative cell and gene therapies to market, scalable commercial strategies are critical to successfully delivering these therapies to patients. The delivery of cell and gene therapies depends on well-designed supply chains.
Scaling your supply chain up to achieve this requires having, or finding partners with, proven experience in navigating supply chain complexities, coordinating logistics involving multiple stakeholders, and creating customizable solutions to help your company scale efficiently and serve your specific needs from clinical research through to commercial manufacture.
Register for this upcoming webinar for expert insights into creating scalable commercial supply chain for emerging autologous and allogenic therapies.
Attendees will learn:
- How to prepare to meet the inevitable increase in supply chain variability through scale-up
- How to allocate sufficient time and resources to mitigate growing supply chain risk as the scale of operations increases
- What proactive preparations and collaborative strategies can be employed to ensure access to the necessary capabilities when you need them
- How to ready your organisation for supply chain success in a highly variable environment where multiple products are in motion at any given time